Physician

Araceli Cempron Mesiona-Brucal, M.D.

According to 2025 Medicare claims, Araceli Mesiona-Brucal, M.D. (NPI: 1578572517) practices internal medicine in the Niles, MI market, with the plurality of this provider's patient population coming from Berrien, MI. This provider's primary affiliated billing organization is ARACELI C MESIONA-BRUCAL MD PLLC (NPI: 1821491283) and primary practice location at 49098-9761. Mesiona-Brucal is affiliated with the West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Mesiona-Brucal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 338 traditional Medicare patients, billed 1,749 HCPCS/CPT codes, and received $121,653 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 11,969 prescription claims across 644 beneficiaries totaling $1,089,863 in drug costs, led by Eliquis (Apixaban). DME data shows 103 claims. Open Payments data shows 6 records totaling $110. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, reported payments started with an early spike, then settled into a lower baseline, moving from $48,547 to $35,503.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	611	3,715	$174,765
2016	541	3,052	$134,164
2017	595	3,503	$154,519
2018	522	2,978	$139,261
2019	488	2,737	$138,295
2020	394	2,001	$118,087
2021	452	2,396	$166,580
2022	398	2,218	$149,327
2023	366	2,029	$131,049
2024	338	1,749	$121,653

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	713	15,846	$904,661
2016	692	13,354	$775,168
2017	703	14,113	$778,818
2018	712	13,879	$834,574
2019	686	12,938	$845,820
2020	614	11,595	$857,934
2021	672	12,043	$918,170
2022	663	12,958	$1,008,971
2023	657	12,194	$1,101,520
2024	644	11,969	$1,089,863

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	341	1,313	$62,225
2016	295	1,044	$36,057
2017	176	638	$19,415
2018	131	593	$15,196
2019	130	536	$14,751
2020	86	381	$10,452
2021	80	364	$8,557
2022	62	256	$5,145
2023	58	231	$7,465
2024	22	103	$8,326

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	220	220	$131
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	279	660	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	148	246	$58
G0008	Administration of influenza virus vaccine	107	107	$31
36415	Insertion of needle into vein for collection of blood sample	149	231	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	164	8,694	$160,294
Ozempic	Semaglutide	86	4,162	$128,825
Mounjaro	Tirzepatide	85	2,912	$103,858
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	117	5,040	$103,619
Jardiance	Empagliflozin	66	4,700	$86,583

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	14	$7,196
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	22	56	$883
K0001	Standard wheelchair	Y	N/R	16	$221
A4259	Lancets, per box of 100	N	N/R	17	$26

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$110	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Araceli Cempron Mesiona-Brucal, M.D.?

Tedicare shows public-source Medicare data for Araceli Cempron Mesiona-Brucal, M.D. (NPI 1578572517), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Araceli Cempron Mesiona-Brucal, M.D. have ACO affiliation data?

Araceli Cempron Mesiona-Brucal, M.D. is shown with ACO affiliation data for West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626).

What billing organization is linked to Araceli Cempron Mesiona-Brucal, M.D.?

Araceli Cempron Mesiona-Brucal, M.D. is linked to ARACELI C MESIONA-BRUCAL MD PLLC (billing NPI 1821491283) in the available physician profile data.

Does Araceli Cempron Mesiona-Brucal, M.D. have Open Payments data?

Araceli Cempron Mesiona-Brucal, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.